Anticoagulation in COVID-19: A Systematic Review, Meta-analysis, and Rapid Guidance From Mayo Clinic

A higher risk of thrombosis has been described as a prominent feature of coronavirus disease 2019 (COVID-19). This systematic review synthesizes current data on thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19. We included 37 studies from 4070 unique citations. Meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: McBane, Robert D., Torres Roldan, Victor D., Niven, Alexander S., Pruthi, Rajiv K., Franco, Pablo Moreno, Linderbaum, Jane A., Casanegra, Ana I., Oyen, Lance J., Houghton, Damon E., Marshall, Ariela L., Ou, Narith N., Siegel, Jason L., Wysokinski, Waldemar E., Padrnos, Leslie J., Rivera, Candido E., Flo, Gayle L., Shamoun, Fadi E., Silvers, Scott M., Nayfeh, Tarek, Urtecho, Meritxell, Shah, Sahrish, Benkhadra, Raed, Saadi, Samer Mohir, Firwana, Mohammed, Jawaid, Tabinda, Amin, Mustapha, Prokop, Larry J., Murad, M. Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mayo Foundation for Medical Education and Research 2020
Materias:
Consensus Recommendation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458092/
https://www.ncbi.nlm.nih.gov/pubmed/33153635
http://dx.doi.org/10.1016/j.mayocp.2020.08.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458092/
https://www.ncbi.nlm.nih.gov/pubmed/33153635
http://dx.doi.org/10.1016/j.mayocp.2020.08.030

Ejemplares similares